DOI: http://dx.doi.org/10.18203/2349-3933.ijam20192276

Multiple myeloma with primary systemic amyloidosis affecting cutaneous, gastro intestinal and cardio-vascular system

Mohammed Feros A. S., Lokesh Shanmugam

Abstract


Amyloidosis refers to a group of disorders characterized by extracellular deposition of protein fibrils. Primary systemic amyloidosis is commonly due to an underlying plasma cell dyscrasia. Infiltrative amyloid cardiomyopathy is a rare cause of predominantly diastolic myocardial disease. Restrictive cardiomyopathy is the main finding in cardiac amyloidosis and results from the replacement of normal myocardial contractile elements by infiltration and interstitial deposits of amyloid, leading to alterations in cellular metabolism, calcium transport, receptor regulation, and cellular edema. Injury can also occur from circulating light chains in the absence of amyloid fibril formation. Cardiac amyloidosis should be considered in any patient presenting with congestive heart failure, preserved systolic function, and a discrepancy between a low QRS voltage on electrocardiography and an apparent left ventricular hypertrophy on sonogram. The pattern of left ventricular diastolic dysfunction changes during the course of amyloidosis and the classically described restrictive physiology occurs only in advanced stages of the disease. This is a case report where an unusual extensive cutaneous and cardiac involvement provided the sign of widespread systemic deposition of amyloid protein which eventually led to the diagnosis of multiple myeloma.


Keywords


Cutaneous Amyloidosis, Diastolic dysfunction, Multiple Myeloma, Restrictive cardiomyopathy

Full Text:

PDF

References


Souza Júnior J de, Schettini RA, Tupinambá WL, Schettini APM, Chirano CAR, Massone C. Amiloidose localizada cutânea primária nodular: relato de caso. An Bras Dermatol. 2011 Oct;86(5):987-90.

Hofer JF, Wimmer G. Severe heart failure from light chain cardiomyopathy. Z Kardiol. 2003;92:90-5.

Hassan W, Al-Sergani H, Mourad W, Tabbaa R. Amyloid Heart Disease. Tex Heart Inst J. 2005;32(2):178-84.

López L, González K, Navarrete G, Novales J, Guarneros A, Cortés B, et al. Multiple myeloma and systemic amyloidosis. Int J Dermatol. 2008 Feb;47(2):165-7.

Silverstein SR. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J. 2005 Mar 1;11(1):5.

Oliveira EVL de, Pozetti ACG, Pozetti EM de O, Antonio JR, Michalany NS. Primary systemic amyloidosis associated with multiple myeloma. An Bras Dermatol. 2012 Feb;87(1):119-22.

Reisinger J, Dubrey SE, Lavalley M, Skinner M, Falk RH. Electrophysiologic abnormalities in AL (Primary) Amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997;30:1046-51.

Mathew V, Olson LJ, Gertz MA, Hayes DL. Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol. 1997 Dec 1;80(11):1491-2.

Pellikka PA, Holmes DR, Edwards WD, Nishimura RA, Tajik AJ, Kyle RA. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med. 1988 Mar;148(3):662-6.

Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995 Jan;32(1):45-59.

Yücel A, Akman A, Denli YG, Acar MA, Karakas M, Hazar B, et al. A case of systemic amyloidosis associated with multiple myeloma presented as macroglossia and purpura. J Eur Acad Dermatol Venereol JEADV. 2004 May;18(3):378-9.